This website uses cookies so that we can provide you with the best user experience possible. Our Cookie Notice is part of our Privacy Policy and explains in detail how and why we use cookies. To take full advantage of our website, we recommend that you click on “Accept All”. You can change these settings at any time via the button “Update Cookie Preferences” in our Cookie Notice.
Technical cookies are required for the site to function properly, to be legally compliant and secure. Session cookies only last for the duration of your visit and are deleted from your device when you close your internet browser. Persistent cookies, however, remain and continue functioning on repeat visits.
We does not use any cookie based Analytics or tracking on our websites; see details here.
Personalisation cookies collect information about your website browsing habits and offer you a personalised user experience based on past visits, your location or browser settings. They also allow you to log in to personalised areas and to access third party tools that may be embedded in our website. Some functionality will not work if you don’t accept these cookies.
13 July 2020
CMS has successfully represented interests of GE Healthcare in several court proceedings against the Russian healthcare regulatory authority (Roszdravnadzor). We could invalidate the regulator’s refusal from registering one of GE Healthcare products, modern ultrasound diagnostic system, in Russia. The positive decision of the court of first instance has been awarded in July 2020 and the regulator is bound to authorise the client’s product and allow its circulation in Russia.
This case is specific since it is a very rare precedent in Russia when a major medical device manufacturer decides to appeal a decision of the healthcare authority.
Vsevolod Tyupa, Head of Life Sciences at CMS Russia, led the team and was supported by the senior associate Igor Sokolov and associates Alexey Shadrin and Anastasia Entyakova.